WILMINGTON, Mass., March 16, 2012 (GLOBE NEWSWIRE) -- Dermatology company DUSA Pharmaceuticals, Inc.® (Nasdaq:DUSA), introduced an actinic keratosis (AK) awareness campaign called "Spot Signs of AK" at the American Academy of Dermatology 70th Annual Meeting in San Diego, California today. The goal of the campaign is to inform people about the dangers of cumulative sun damage and how it can cause AKs—a precancerous skin condition. AKs have the potential to progress to squamous cell carcinoma (SCC), the second most common skin cancer. While most AKs remain benign, approximately 10 percent develop into SCC within an average of two years. The campaign was spearheaded with the launch of a new website, www.spotsignsofAK.com.
